U1167-RID-AGE-Facteurs de Risque et Déterminants Moléculaires des Maladies Liées au Vieillissement, Institut Pasteur de Lille, University Lille, Inserm, CHU Lille, F-59000 Lille, France.
Institut Polytechnique UniLaSalle, Université d'Artois, ULR 7519, Equipe PETALES, 60000 Beauvais, France.
Food Res Int. 2024 Nov;195:114967. doi: 10.1016/j.foodres.2024.114967. Epub 2024 Aug 23.
Dietary advanced glycation end-products (dAGEs) accumulate in organs and are thought to initiate chronic low-grade inflammation (CLGI), induce glycoxidative stress, drive immunosenescence, and influence gut microbiota. Part of the toxicological interest in glycation products such as dietary carboxymethyl-lysine (dCML) relies on their interaction with receptor for advanced glycation end-products (RAGE). It remains uncertain whether early or lifelong exposure to dAGEs contributes physiological changes and whether such effects are reversible or permanent. Our objective was to examine the physiological changes in Wild-Type (WT) and RAGE KO mice that were fed either a standard diet (STD - 20.8 ± 5.1 µg dCML/g) or a diet enriched with dCML (255.2 ± 44.5 µg dCML/g) from the perinatal period for up to 70 weeks. Additionally, an early age (6 weeks) diet switch (dCML→STD) was explored to determine whether potential harmful effects of dCML could be reversed. Previous dCML accumulation patterns described by our group were confirmed here, with significant RAGE-independent accumulation of dCML in kidneys, ileum and colon over the 70-week dietary intervention (respectively 3-fold, 17-fold and 20-fold increases compared with controls). Diet switching returned tissue dCML concentrations to their baseline levels. The dCML-enriched diet had no significative effect on endogenous glycation, inflammation, oxidative stress or senescence parameters. The relative expression of TNFα, VCAM1, IL6, and P16 genes were all upregulated (∼2-fold) in an age-dependent manner, most notably in the kidneys of WT animals. RAGE knockout seemed protective in this regard, diminishing age-related renal expression of TNFα. Significant increases in TNFα expression were detectable in the intestinal tract of the Switch group (∼2-fold), suggesting a higher sensitivity to inflammation perhaps related to the timing of the diet change. Minor fluctuations were observed at family level within the caecal microbiota, including Eggerthellaceae, Anaerovoracaceae and Marinifilaceae communities, indicating slight changes in composition. Despite chronic dCML consumption resulting in higher free CML levels in tissues, there were no substantial increases in parameters related to inflammageing. Age was a more important factor in inflammation status, notably in the kidneys, while the early-life dietary switch may have influenced intestinal susceptibility to inflammation. This study affirms the therapeutic potential of RAGE modulation and corroborates evidence for the disruptive effect of dietary changes occurring too early in life. Future research should prioritize the potential influence of dAGEs on disease aetiology and development, notably any exacerbating effects they may have upon existing health conditions.
饮食晚期糖基化终产物(dAGEs)在器官中积累,被认为会引发慢性低度炎症(CLGI),诱导糖基化应激,驱动免疫衰老,并影响肠道微生物群。人们对糖基化产物(如饮食羧甲基赖氨酸(dCML))的部分毒理学兴趣依赖于它们与晚期糖基化终产物受体(RAGE)的相互作用。目前尚不确定早期或终生接触 dAGEs 是否会导致生理变化,以及这些影响是否可逆或永久。我们的目的是研究在围产期至 70 周期间,分别用标准饮食(STD-20.8±5.1µg dCML/g)或富含 dCML 的饮食(255.2±44.5µg dCML/g)喂养的野生型(WT)和 RAGE KO 小鼠的生理变化。此外,还探索了早期(6 周)饮食转换(dCML→STD),以确定 dCML 的潜在有害影响是否可以逆转。我们小组之前描述的 dCML 积累模式在这里得到了证实,在 70 周的饮食干预过程中,肾脏、回肠和结肠中 dCML 的积累明显与 RAGE 无关(与对照组相比,分别增加了 3 倍、17 倍和 20 倍)。饮食转换使组织 dCML 浓度恢复到基线水平。富含 dCML 的饮食对内源性糖基化、炎症、氧化应激或衰老参数没有显著影响。TNFα、VCAM1、IL6 和 P16 基因的相对表达均呈年龄依赖性上调(约 2 倍),在 WT 动物的肾脏中最为明显。RAGE 基因敲除在这方面似乎具有保护作用,降低了 WT 动物肾脏中与年龄相关的 TNFα 表达。在 Switch 组的肠道中可检测到 TNFα 表达的显著增加(约 2 倍),这表明炎症的敏感性可能与饮食改变的时间有关。盲肠微生物组中家庭水平的波动较小,包括 Eggerthellaceae、Anaerovoracaceae 和 Marinifilaceae 群落,表明组成略有变化。尽管慢性 dCML 消耗导致组织中游离 CML 水平升高,但与炎症老化相关的参数没有显著增加。年龄是炎症状态的一个更重要因素,特别是在肾脏中,而早期生活中的饮食转换可能影响肠道对炎症的敏感性。这项研究证实了 RAGE 调节的治疗潜力,并证实了饮食改变发生得过早对健康的破坏性影响。未来的研究应优先考虑 dAGEs 对疾病发病机制和发展的潜在影响,特别是它们对现有健康状况的任何加重作用。